Fifth, there are other influential factors in shaping the burden of disease, such as the prevalence of prostate-specific antigen-based prostate cancer screening, which could introduce bias into estimates because accurate information for each country was not available. This evidence concerns the gene KLK3 and prostate carcinoma.